Willow Biosciences (CSE: WLLW), a leading developer of
biosynthetic production systems for high-value, plant-derived active
pharmaceutical ingredients (“APIs”) and intermediates, was recently covered in
a research report by Eight Capital. Per the report, Eight Capital issued a
‘Buy’ rating and a target price of $4.50 for WLLW, determined in part by
Willow’s chosen method of cannabinoid production, biosynthesis, which holds the
potential to disrupt the industry. The report also detailed upcoming catalysts
for the company, including the potential formation of partnerships and
agreements; quantitative milestones demonstrating increased throughput of the
company’s proprietary yeast strains; planned uplisting to the Toronto Stock
Exchange; and securing intellectual property (“IP”) assets. For detailed
information regarding the research report, contact Info@WillowBio.com.
For more information, visit www.WillowBio.com.
About Willow Biosciences Inc.
Willow is a Canadian biotechnology company based in Calgary,
Alberta, that produces high purity, plant-derived compounds that provide
building blocks for the global pharmaceutical, health and wellness, and
consumer packaged goods industries. Willow’s current focus is in the production
of cannabinoids for the treatment for pain, anxiety, obesity, brain disorders,
among other significant indications. Willow’s science team has a proven track
record of developing manufacturing technologies for high purity compounds in
pain and cancer treatments. Willow’s manufacturing process creates a
consistent, scalable and sustainable product that allows for the discovery and
development of new life changing drugs.
NOTE TO INVESTORS: The latest news and updates
relating to WLLW are available in the company’s newsroom at http://ibn.fm/WLLW
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide
a rapid summary of corporate news that catch the attention of QualityStocks.
QualityStocksBreaks are designed to keep investors up to date on important and
breaking news in the small-cap and micro-cap markets. Spanning all industries,
including energy, entertainment, telecommunications, healthcare, retail and
more, these news breaks deliver opportunities the investment community may have
missed. Whether it is earnings results, mergers and acquisitions, or any other
market-moving news, our news breaks keep you in the know. QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment